ArcScan Insight 100

FDA UDI

Class II (US FDA UDI)

by Arcscan, Inc.

Identity

Trade Name: ArcScan Insight 100 FDA UDI
Generic Name: Ophthalmic ultrasound imaging system FDA UDI
Model / Reference: EyeSeal Disposable FDA UDI

Identifiers

Catalog Number: ED1 FDA UDI
Primary DI / UDI-DI: B017ED102 FDA UDI
FDA Product Code: ITX FDA UDI
IYO FDA UDI
GMDN Term: Ophthalmic ultrasound imaging system FDA UDI

Classification

Device Class: Class II FDA UDI
Regulation Number: 892.1570 FDA UDI
892.1560 FDA UDI
Commercial Distribution: In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

FDA UDI

Contains Latex

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

FDA UDI

Convenience Kit

FDA UDI

Combination Product

FDA UDI

HCT/P

FDA UDI

Premarket Exempt

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

FDA UDI

Category: Ophthalmic ultrasound imaging system

ArcScan Insight 100 by Arcscan, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Ophthalmic ultrasound imaging system.

A-scan probe — Nidek, Inc. · Class II
Ultrasonic A/B Scanner for Ophthalmology — Meda , Ltd. · Class II
Eli Ezer — U.S. OPHTHALMIC, L.L.C. · Class II
Ellex — ELLEX MEDICAL PTY LTD · Class II
LIGHTSonic B UBM — Light-Med(Usa), Inc. · Class II
Ophthalmic Ultrasound Examination Instrument — CHONGQING SUNKINGDOM MEDICAL INSTRUMENT CO., LTD · Class II
B-scan Plus- VET — ACCUTOME, INC. · Class II
A-scan probe — Nidek, Inc. · Class II

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Source	Region	Type	Cert / Approval No.	Class	Status
FDA UDI	United States	FDA UDI	Registered in GUDID	Class II	Pending data

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer: Arcscan, Inc.

Sources (1)

FDA UDI 1bc953aa-4784-4850-8668-69c9819ba97b 34 fields · synced May 30, 2026